NCT05846958

Brief Summary

BACKGROUND: Carpal tunnel syndrome (CTS), the most common entrapment neuropathy of the upper extremity, is caused by compression of the median nerve as it travels through the carpal tunnel CTs is a very common complication found in pregnancy, which is reported as high as 62% in pregnant females. The functioning of median nerve is compromised in almost all pregnant females especially during the third trimester of pregnancy, the majority may still feel some symptoms up to 3 years after delivery. Many clinicians have used LLLT on acupuncture points, which is called laser acupuncture (LA), to treat many clinical problems, such as musculoskeletal pain, lateral epicondylitis, headaches, etc. In contrast with traditional acupuncture needles, LA is a non-invasive therapy that does not cause tingling/pain during procedures Objective: to determine efficacy of laser acupuncture on electrophysiological parameters of median nerve in postpartum women

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2023

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 6, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 6, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2023

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 28, 2023

Completed
Last Updated

May 6, 2023

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

April 6, 2023

Last Update Submit

April 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • sensory nerve conduction velocity (SNCV) measured in m/s

    will be measured at the beginning of the study and at the end of the treatment program througth EMG

    4 weeks

Secondary Outcomes (2)

  • Hand grip strength in Kg

    4 weeks

  • Symptoms severity and functional capacity (Score)

    4 weeks

Study Arms (2)

laser acupuncture

EXPERIMENTAL

Each patient in this group will receive laser acupuncture based on the recommended LLLT treatment doses for CTS of the World Association of Laser Therapy.

Device: laser acupunctureDevice: night splint

control group

ACTIVE COMPARATOR

Each patient in this group will wear night splint every night for 4 weeks

Device: night splint

Interventions

Each patient in experimental group will receive laser acupuncture for 10 s with at least 4J/point for each point.10 minutes, three times per week for 4 weeks (total of 12 sessions) nieght splint for 4 weeks .

laser acupuncture

wearing night splint for 4 weeks

control grouplaser acupuncture

Eligibility Criteria

Age25 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsPostpartum women with mild to moderate carpal tunnel syndrome will participate in this study
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Their BMI will be range from 25 to 30 Kg/m2.
  • The electrophysiological evidence of mild or moderate median nerve lesion at wrist (mild: sensory nerve latency \>3.5 ms at third digit, moderate: sensory nerve latency \>3.5 ms at third digit and median motor latency\>4.2 ms)
  • Positive phalen's test.
  • Positive tinel's test.
  • Carpal tunnel of dominant hand could be participated.

You may not qualify if:

  • History of brachial plexopathy or malignancy.
  • Radial, ulnar neuropathy, proximal median neuropathy or polyneuropathy.
  • Previous wrist surgery or steroid injection for carpal tunnel syndrome.
  • History of trauma, fracture, deformity or inflammation in the wrist, such as rheumatoid arthritis.
  • Coagulation abnormalities, pregnancy, fever and infections.
  • Skin disease and skin cancer.
  • Spots, birthmarks or tattoos over the work points. 8- Pacemaker and implementable medical devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Out clinic, Faculty of physical therapy

Dokki, Giza Governorate, 12613, Egypt

RECRUITING

Study Officials

  • Afaf M Botla, Professor

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Afaf M Botla, professor

CONTACT

Manal A ElShafei, Lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

April 6, 2023

First Posted

May 6, 2023

Study Start

April 1, 2023

Primary Completion

July 20, 2023

Study Completion

July 28, 2023

Last Updated

May 6, 2023

Record last verified: 2023-04

Locations